Law + science + public communication · Organization-specific concept
Destigmatization Toolkit for Psychoactive Plant Medicine
Live concept · independently initiated
Give different audiences a source-grounded way to discuss psychoactive plant medicine without flattening pharmacology, law, history, or policy.
Controlled visual demonstration
Current live interface
This sandboxed preview shows the current public interface. Open the full site to use the build in its intended window.
What I noticed
Arguments about psychoactive plant medicine routinely fail because clinicians, policymakers, religious communities, lawyers, journalists, and general readers enter through different concerns and standards of proof. A single advocacy narrative can overstate clinical evidence, ignore legal exposure, erase Indigenous authority, or use language that alienates the audience before the underlying evidence is considered.
What I researched
The toolkit organizes twenty-nine sections and 222 cited sources across stigma architecture, pharmacology, research history, substance profiles, federal and state law, implementation data, economics, safety, evidence quality, audience-specific communication, Indigenous communities, language, impermissible claims, religious use, intellectual property, access, insurance, criminal defense, practitioner compliance, business formation, tourism, youth considerations, funding, and recent RFRA litigation. Six audience paths reorder that same evidence for different starting questions.
What exists
A 222-source reference organized into twenty-nine sections for six audiences.
Who it serves
Legal professionals, clinicians, policymakers, educators, advocates, and the public.
What it demonstrates
Primary-source synthesis, audience-specific translation, stigma-aware communication, and large-scale reference design.
Current evidence
The live artifact verifies a navigable twenty-nine-section reference, six audience routes, endnote area, legal and medical disclaimers, institutional and author attribution, and the presentation of 222 sources. It is independently initiated and is not represented as commissioned client work. This portfolio audit does not independently cite-check all 222 sources, validate every clinical or policy claim, confirm that every citation is primary, establish cultural authority, or treat collaboration language as endorsement by every named person or institution. Time-sensitive law and science require current primary-source and professional review.
Verified build record
What is actually running, and what it is not.
LiveLive · 222 sources, verification record committed
The problem. Six audiences — clinicians, employers, families, journalists, policymakers, patients — need the same pharmacology and the same law, but each needs it framed for a different decision, and a single undifferentiated explainer serves none of them.
What it does. Covers pharmacology, law and policy for psychoactive plant medicine across six audience paths, over a 222-source reference base. A verification record is committed alongside the site, so the citation set can be re-checked by someone who does not trust the author.
Built on. A static site with a committed verification manifest, served from Vercel.
This record is generated from the same inventory as the complete build index: the production URL was checked at the last regeneration, and the status line above repeats what the build reports about itself rather than restating an intention.